MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Supplier Stories for the Week of April 12

<p><a href="">Resolution Medical</a>, an in vitro diagnostic and medical device manufacturer, is using the <a href="http://WWW.CARBON3D.COM">Carbon</a> Digital Manufacturing Platform to produce nasopharyngeal swabs for COVID-19 testing. Made using the Carbon Digital Light Synthesis (DLS) technology as well as KeySplint Soft Clear material from Keystone Industries, the Resolution Medical Lattice Swab is classified by FDA as a Class I 510(k) exempt in vitro diagnostic medical device, it was reported in a news release. If needed, the operation could be scaled up to produce millions of swabs per week.</p><p>The lattice was designed using Carbon’s Lattice Engine software, which generated a hollow structure that promotes specimen collection efficiency and a flexible geometry for patient comfort. The swab is now undergoing clinical evaluation by clinicians at multiple institutions, including Beth Israel Deaconess Medical Center (BIDMC), a teaching hospital affiliated with Harvard Medical School, and Stanford Medicine, it was reported.</p><p>“We are proud to be collaborating with digital manufacturing company, Carbon, to produce the Lattice Swab,” said Shawn Patterson, founder and president of Resolution Medical, in the release. “We have worked together urgently to get this product into the hands of healthcare workers to help address immediate needs for increased COVID-19 testing. At scale, we plan to supply over 1 million swabs per week.”</p><p>Added Dr. Joseph DeSimone, Co-Founder and Executive Chairman at Carbon: “Triggered by the COVID-19 pandemic, Carbon’s engineers and material scientists quickly sprung to action to identify the KeySplint Soft Clear material as having the right balance of properties to make a soft, flexible swab with appropriate strength that could be printed with precision using the Carbon M2 at 75 micron pixels. Resolution Medical, our production partner since 2018, has been amazing in leading the effort to launch the product.”</p><p>To develop, test, and refine the swabs, Carbon and Resolution Medical collaborated with a group of researchers led by clinical pathologist Ramy Arnaout, MD, PhD, associate director of the clinical microbiology laboratories at BIDMC and assistant professor of pathology at Harvard Medical School. They also worked with Kit Parker, PhD, a lieutenant colonel in the United States Army Reserve and a professor of bioengineering and applied physics at Harvard University; and with a team of faculty and laboratory and nursing staff at Stanford Medicine, including Ryan Van Wert, MD, clinical assistant professor of medicine; Christina Kong, MD, medical director of the Pathology and Clinical Laboratory; and Jennifer Fralick, administrative director of Laboratory Services. The 3D Printing for COVID-19 Taskforce at Stanford Medicine has been led by Sridhar Seshadri, PhD, Chief Administrative Officer, Destination Service Lines.</p><p>[Image courtesy of CARBON]</p>
Here’s what was new in the world of medical device suppliers during the week of April 12, with many suppliers responding to needs in light of the COVID-19 pandemic.
TAGS: News
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.